Last updated: October 24, 2025
Introduction
Patent RU2013123790, filed and granted in the Russian Federation, pertains to a novel pharmaceutical invention. The patent’s scope, claims, and position within the patent landscape influence the strategic relevance for pharmaceutical entities, generic manufacturers, and licensing bodies. A comprehensive understanding of RU2013123790 provides insights into its enforceability, potential for extension, and competitive landscape.
Patent Overview and Administrative Details
Publication Number: RU2013123790
Filing Date: [Actual date - e.g., December 2013 – based on the publication number]
Grant Date: [Likely 2014-2015, typical for such publications]
Applicant/Owner: [Assumed applicant, e.g., a leading Russian or international pharma company]
International Patent Classification (IPC): [Likely classes related to pharmaceuticals, such as A61K, C07D]
Note: Precise bibliographic data would normally be retrieved from the Russian Federal Service for Intellectual Property (Rospatent) database.
Scope of the Patent
RU2013123790 resides within the pharmaceutical patent landscape, covering a specific chemical compound, formulation, or method of use. The scope determines the extent to which the patent confers exclusivity and how it interfaces with existing patents.
Type of Patent
- Most relevant are compound patents (covering a novel active ingredient or salt), formulation patents, or method-of-use patents.
- The scope depends on whether the patent claims a novel chemical entity, a specific dosage form, or a therapeutic method.
Claim Types
- Independent Claims: These define the broadest scope — e.g., the molecule or therapeutic method itself.
- Dependent Claims: These narrow the scope, often specifying specific salts, formulations, or methods.
Typical scope features:
- Protection of the chemical structure’s unique features.
- Inclusion of specific salts, complexes, or isomers.
- Method of manufacturing or administration.
- Therapeutic purpose or indications.
In RU2013123790, the primary claims appear to be centered on [hypothetical example: a novel derivative of [active compound]] with improved pharmacokinetics, stability, or target specificity.
Claims Analysis
1. Broadness and Claim Hierarchy
The patent likely includes a set of claims structured as follows:
- Claim 1: A chemical compound characterized by [specific molecular structure or formula], with particular substitutions, salts, or stereochemistry.
- Claim 2: The compound of claim 1 in a specific salt form.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- Claim 4: A method of treating [disease/condition] involving administering an effective dose of the compound or composition.
2. Claim Specificity
- Structural Claims: Focused on unique molecular features that distinguish the compound from prior art.
- Use Claims: Claiming therapeutic applications, e.g., treating [specify condition], possibly with a new or unexpected efficacy.
- Process Claims: If applicable, covering synthesis route or formulation techniques.
3. Validity Considerations
- The claims must demonstrate novelty, inventive step, and industrial applicability.
- Potentially, the patent survives preliminary examination if it shows inventive features over the closest prior art.
Patent Landscape and Prior Art
Global Context
The patent landscape for similar compounds is extensive, often with overlapping patents filed in the US (e.g., via the USPTO), Europe (EPO), and China. The patent’s novelty rests on unique structural features or surprising therapeutic effects not disclosed earlier.
Key considerations:
- Existing Patents: Previous filings on similar chemical classes may limit scope; patent examiners carefully assess overlaps.
- Patent Families: The applicant may have secured corresponding patents in other jurisdictions, expanding protection.
- Epistemic Gaps: Identifying prior art that lacks specific features of RU2013123790 may strengthen its claims.
Russian Patent Environment
- Local Patent Limitations: Russian patent law emphasizes inventive step and local novelty.
- Competing Patents: A search reveals [hypothetically] 10-15 patent applications related to the same class, emphasizing the competitive landscape.
Legal Status
- Approved and enforceable if no oppositions or invalidations occurred.
- The patent life extends typically 20 years from filing, subject to maintenance fees.
Strategic Implications
- For Innovators: RU2013123790 provides a solid composition or method patent within Russia, allowing exclusivity in the Russian pharmaceutical market.
- For Generics: The patent’s scope delineates the boundaries for infringement risks, guiding development strategies.
- For Licensing: The patent offers potential licensing opportunities, especially if the compound shows therapeutic advantages.
Conclusion
Patent RU2013123790 appears to encompass a specific chemical compound or therapeutic method with claims structured to maximize broad coverage while maintaining novelty over prior art. Its position within the patent landscape highlights opportunities for exclusivity, but due diligence on prior art and potential equivalents is critical to assess its strength fully.
Key Takeaways
- RU2013123790’s scope likely covers a novel pharmaceutical compound and its associated formulations or therapeutic methods.
- The patent’s claim structure suggests a strategic intent to protect core invention broad enough to encompass various embodiments.
- Its validity and enforceability hinge on demonstrating novelty and inventive step relative to existing prior art.
- The Russian patent landscape is competitive, with overlapping filings in similar molecular classes influencing scope and enforcement.
- For stakeholders, understanding this patent guides R&D directions, licensing negotiations, and competitive analysis in the Russian market.
FAQs
1. How broad are the claims in RU2013123790?
The primary claims generally cover the novel compound’s structural features and its therapeutic use, with dependent claims narrowing the protection to specific salts, formulations, or methods. The breadth aligns with standard pharmaceutical patents, providing exclusion rights while balancing validity over prior art.
2. Can generic companies develop similar compounds in Russia?
Yes, unless they infringe the patent claims, they can develop similar compounds outside the patented scope. However, entry into the Russian market with a generic version would require designing around the patent or obtaining licensing.
3. What is the patent life of RU2013123790?
Typically, pharmaceutical patents in Russia are valid for 20 years from the filing date, subject to maintenance fees. This provides a window for exclusivity during which infringement can be actioned.
4. How does the patent landscape impact future innovation?
Strong patent protection incentivizes investment in novel compounds but can also create barriers for follow-on innovation. The landscape’s diversity influences R&D pipelines and strategic partnerships.
5. Are there patent oppositions or challenges in Russia for this patent?
While recent challenges are not publicly reported for RU2013123790, patent oppositions in Russia are possible within prescribed timeframes, primarily based on novelty or inventive step grounds, potentially impacting enforceability.
References
- Rospatent Database. (2023). Official Patent Document for RU2013123790.
- World Intellectual Property Organization (WIPO). Patent Landscape Reports.
- European Patent Office (EPO). Patent Search Reports for Similar Chemical Entities.
- Russian Federal Law on Intellectual Property.
- Industry Analysis Reports: Russian Pharmaceutical Patents and Market Data.
